Question · asked by 1 review

HIGH DOSE (greater than or equal to 10 mg/day) vs ANY DOSE ‐ short term: Leaving the study early: insufficient response ‐ When compared with ultra low dose (<2 mg/day)

Population
patients with schizophrenia
Intervention
HIGH DOSE (greater than or equal to 10 mg/day)
Comparison
ANY DOSE ‐ short term
Outcome
Leaving the study early: insufficient response ‐ When compared with ultra low dose (<2 mg/day)

HIGH DOSE (greater than or equal to 10 mg/day) probably leads to lower leaving the study early: insufficient response ‐ When compared with… compared with ANY DOSE ‐ short term (moderate certainty).

What each review found

Include earlier review versions
FindingEffectStudiesGRADE certainty
HIGH DOSE (greater than or equal to 10 mg/day) vs ANY DOSE ‐ short term
Leaving the study early: insufficient response ‐ When compared with ultra low dose (<2 mg/day) · patients with schizophrenia
HIGH DOSE (greater than or equal to 10 mg/day) probably leads to lower leaving the study early: insufficient response ‐ When compared with… compared with ANY DOSE ‐ short term (moderate certainty).
Risperidone dose for schizophrenia (2009) · Cochrane Headline outcomes only
RR 0.66 [0.45, 0.97]1 study · 679 participantsModerate

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Risperidone dose for schizophrenia
2009 · Cochrane Headline outcomes only
Not reportedNot extractedNot assessed
How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.